(Q38777333)

6 September 2017

MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1. (English)

1 reference

6 September 2017

hepatocellular carcinoma

1 reference

Zhijie Tian

1

1 reference

6 September 2017

Hequn Jiang

2

1 reference

6 September 2017

Ying Liu

3

1 reference

6 September 2017

Yong Huang

4

1 reference

6 September 2017

Xin Xiong

5

1 reference

6 September 2017

Hongwei Wu

6

1 reference

6 September 2017

Xiaozhen Dai

7

1 reference

6 September 2017

language of work or name

English

0 references

publication date

15 April 2016

1 reference

Experimental Cell Research

6 September 2017

1 reference

6 September 2017

343

1 reference

6 September 2017

2

1 reference

6 September 2017

135-147

1 reference

Development of molecularly targeted therapies in hepatocellular carcinoma: where do we go now?

6 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Sorafenib: where do we go from here?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Treatment of hepatocellular carcinoma: present and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

RNAi: the nuts and bolts of the RISC machine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

The functions of animal microRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Many roads to maturity: microRNA biogenesis pathways and their regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Oncomirs - microRNAs with a role in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Genetic variation in microRNA networks: the implications for cancer research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

MicroRNAs in cell proliferation, cell death, and tumorigenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

MicroRNA expression profiles classify human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

MicroRNA signatures in human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

The role of microRNA-133b and its target gene FSCN1 in gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Investigating the pretreatment miRNA expression patterns of advanced hepatocellular carcinoma patients in association with response to TACE treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Therapeutic potential of sirtuin-activating compounds in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Sirtuin 1 (SIRT1): the misunderstood HDAC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Mammalian sirtuins: biological insights and disease relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

SIRT1 is significantly elevated in mouse and human prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Antitumor effect of SIRT1 inhibition in human HCC tumor models in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-β2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Glypican-3 as a serum marker for hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

MiR-520d-5p directly targets TWIST1 and downregulates the metastamiR miR-10b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Pluripotent stem cell miRNAs and metastasis in invasive breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

miR-34a repression of SIRT1 regulates apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

MiR-34, SIRT1 and p53: the feedback loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

MicroRNA Regulation of SIRT1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

A novel interplay between oncogenic PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of liver cancer cell motility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

MiR-133b regulates the expression of the Actin protein TAGLN2 during oocyte growth and maturation: a potential target for infertility therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK/Sirt1/PGC-1α signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

SIRT1 promotes proliferation and inhibits apoptosis of human malignant glioma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

The role of glypican-3 in the regulation of body size and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Specificity and versatility in tgf-beta signaling through Smads

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Signaling mechanisms of the epithelial-mesenchymal transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

Can we safely target the WNT pathway?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.027

SIRT1 promotes tumorigenesis of hepatocellular carcinoma through PI3K/PTEN/AKT signaling.

7 January 2021

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.3892/OR.2012.1788

Identifiers

DOI

10.1016/J.YEXCR.2016.03.027

1 reference

6 September 2017

1 reference